Detalhe da pesquisa
1.
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission.
J Infect Dis
; 228(2): 212-223, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042518
2.
Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali.
Lancet Microbe
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705163
3.
Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ouélessébougou, Mali.
Sci Rep
; 13(1): 9522, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308503
4.
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.
Lancet Microbe
; 4(3): e140-e148, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681093
5.
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.
iScience
; 26(9): 107619, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670790
6.
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.
Lancet Microbe
; 3(5): e336-e347, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544095
7.
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults.
Lancet Infect Dis
; 22(11): 1596-1605, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963275
8.
Monoclonals against malaria: the promise of passive protection.
Lancet Infect Dis
; 23(5): 514-516, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708739